Growth Metrics

Rigel Pharmaceuticals (RIGL) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 7.81%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.81%
Dec 31, 2025 -12.34%
Sep 30, 2025 7.50%
Jun 30, 2025 11.07%
Mar 31, 2025 1.20%
Dec 31, 2024 -3.73%
Sep 30, 2024 6.29%
Jun 30, 2024 3.11%
Mar 31, 2024 24.84%
Dec 31, 2023 5.85%
Sep 30, 2023 1.03%
Jun 30, 2023 7.32%
Mar 31, 2023 10.87%
Dec 31, 2022 42.47%
Sep 30, 2022 8.87%
Jun 30, 2022 -3.41%
Mar 31, 2022 2.79%
Dec 31, 2021 4.38%
Sep 30, 2021 -9.74%
Jun 30, 2021 27.52%
Mar 31, 2021 19.67%
Dec 31, 2020 -18.93%
Sep 30, 2020 29.23%
Jun 30, 2020 16.89%
Mar 31, 2020 28.45%
Dec 31, 2019 8.65%
Sep 30, 2019 6.97%
Jun 30, 2019 9.62%
Mar 31, 2019 27.11%
Dec 31, 2018 8.18%
Sep 30, 2018 18.17%
Jun 30, 2018 -16.48%
Mar 31, 2018 -9.15%
Dec 31, 2017 26.81%
Sep 30, 2017 -25.13%
Jun 30, 2017 -19.79%
Mar 31, 2017 -26.08%
Dec 31, 2016 -11.05%
Sep 30, 2016 92.84%
Jun 30, 2016 4.85%
Mar 31, 2016 -7.09%
Dec 31, 2015 -20.74%
Sep 30, 2015 -17.61%
Jun 30, 2015 -14.09%
Mar 31, 2015 -12.80%
Dec 31, 2014 -20.99%
Sep 30, 2014 -12.36%
Jun 30, 2014 -12.66%
Mar 31, 2014 -14.91%
Dec 31, 2013 -25.64%
Sep 30, 2013 -60.12%